MYD88 and melanoma: Data from our laboratory demonstrated that Icariside II enhanced paclitaxel-induced apoptosis in human melanoma cells, which might be due to its inhibition on paclitaxel-induced activation of TLR4-MyD88-ERK signaling [48].